Breakthrough trial aims to stop strokes in kids with sickle cell

NCT ID NCT06526117

Recruiting now Prevention Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Mar 07, 2026 · Last updated May 20, 2026 · Updated 11 times

Summary

This study tests whether a daily medicine called hydroxyurea can prevent strokes in children with sickle cell anemia who are at high risk. About 220 children in Nigeria will receive low or moderate doses of the drug and be monitored for strokes or mini-strokes. The goal is to see if this simple treatment works in real-world clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aminu Kano Teaching Hospital
RECRUITING

Kano, Nigeria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Murtala Muhammad Specialist Hospital
RECRUITING

Kano, Nigeria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SICKLE CELL DISEASE STROKE